028 Off label use of Siromilus Eluting Stent increases the rate of death and stent thrombosis without jeopardizing the efficacy: EVASTENT matched cohort registry

MLA

Jean-Louis Quesada, et al. “028 Off Label Use of Siromilus Eluting Stent Increases the Rate of Death and Stent Thrombosis without Jeopardizing the Efficacy: EVASTENT Matched Cohort Registry.” Archives of Cardiovascular Diseases Supplements, no. 1, p. 9. EBSCOhost, https://doi.org/10.1016/S1878-6480(11)70030-1. Accessed 29 Jan. 2025.

APA

Jean-Louis Quesada, Stephane Rias, Alison Foote, Gilles Barone-Rochette, Gérald Vanzetto, Jacques Machecourt, Nicolas Danchin, & Aude Boignard. (n.d.). 028 Off label use of Siromilus Eluting Stent increases the rate of death and stent thrombosis without jeopardizing the efficacy: EVASTENT matched cohort registry. Archives of Cardiovascular Diseases Supplements, 1, 9. https://doi.org/10.1016/S1878-6480(11)70030-1

Chicago

Jean-Louis Quesada, Stephane Rias, Alison Foote, Gilles Barone-Rochette, Gérald Vanzetto, Jacques Machecourt, Nicolas Danchin, and Aude Boignard. 2025. “028 Off Label Use of Siromilus Eluting Stent Increases the Rate of Death and Stent Thrombosis without Jeopardizing the Efficacy: EVASTENT Matched Cohort Registry.” Archives of Cardiovascular Diseases Supplements, no. 1: 9. Accessed January 29. doi:10.1016/S1878-6480(11)70030-1.